Mesoblast (MESO) Stock Highlights

17.3 | +3.78%

2025-01-21 03:42:55

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Statistics

Range Today

15.92 17.65

Volume Today 535K

Range 1 Year

1.61 22

Volume 1 Year 191.1M

Range 3 Year

1.61 22

Volume 3 Year 236.54M

Range 10 Year

1.61 42.56

Volume 10 Year 396.7M

Highlights

Market Capitalization 2B (mid)

Floating Shares 848.92M

Current Price 17.3

Price To Earnings -8.75

Price To Revenue 3.35K

Price To Book 41.09

Earnings Per Share -1.82

Payout Ratio 0%

Performance

Latest +3.78%

1 Month +36.22%

3 Months +77.44%

6 Months +130.67%

1 Year +861.11%

3 Years +88.86%

5 Years +2.49%

10 Years -47.92%

Benchmarks

Market Capitalization

233 / 368

Gross Profits

194 / 278

Total Revenue

191 / 300

Total Rank

198 / 368

Free Cashflow

237 / 352

Performance 5 years

111 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.